Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2005; 46:1466-1472, doi:10.1016/j.jacc.2005.05.082 (Published online 22 September 2005).
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2005.05.082v1
46/8/1466    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Casserly, I. P.
Right arrow Articles by Yadav, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casserly, I. P.
Right arrow Articles by Yadav, J. S.

CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY

Slow-Flow Phenomenon During Carotid Artery Intervention With Embolic Protection Devices

Predictors and Clinical Outcome

Ivan P. Casserly, MB, BCh*, Alex Abou-Chebl, MD{dagger}, Robert B. Fathi, MD, PhD{dagger}, David S. Lee, MD{dagger}, Jacqueline Saw, MD{ddagger}, Jose E. Exaire, MD§, Samir R. Kapadia, MD{dagger}, Christopher T. Bajzer, MD{dagger} and Jay S. Yadav, MD{dagger},*

* Denver Veterans Affairs Medical Center and University of Colorado Health Sciences Center, Denver, Colorado
{dagger} Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio
{ddagger} Vancouver General Hospital, Vancouver, Canada
§ National Institute of Health, Mexico City, Mexico

Manuscript received January 26, 2005; revised manuscript received May 18, 2005, accepted May 31, 2005.

* Reprint requests and correspondence: Dr. Jay S. Yadav, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk F25, Cleveland, Ohio, 44195 (Email: yadavj{at}ccf.org).

OBJECTIVES: The purpose of this research was to define the predictors of the "slow-reflow" phenomenon during carotid artery intervention with filter-type embolic protection devices (EPDs) and to determine its prognostic significance.

BACKGROUND: During carotid artery intervention using filter-type EPDs, we have observed cases in which there is angiographic evidence of a significant reduction in antegrade flow in the internal carotid artery proximal to the filter device, termed "slow-flow." The predictors of this phenomenon and its prognostic significance are unknown.

METHODS: Using a single-center prospective carotid intervention registry, patients with slow-flow were compared to patients with normal flow during carotid intervention with respect to clinical, procedural, and lesion characteristics, and the 30-day incidence of death and stroke.

RESULTS: A total of 414 patients underwent 453 carotid artery interventions using EPDs. Slow-flow occurred in 42 patients (10.1%) undergoing 42 carotid interventions (9.3%), and most commonly occurred after post-stent balloon dilatation (71.4%). Multivariate logistic regression analysis identified the following predictors of slow-flow: recent history (<6 months) of stroke or transient ischemic attack (odds ratio [OR] 2.8, 95% confidence interval [CI] 1.4 to 5.6, p = 0.004), increased stent diameter (OR 1.4, 95% CI 1.02 to 1.94, p = 0.044), and increased patient age (OR 1.05, 95% CI 1.01 to 1.09, p = 0.025). Among patients with slow-flow, the 30-day incidence of stroke or death was 9.5% compared to 2.9% in patients with normal flow (chi-square = 4.73, p = 0.03). This difference was driven by the disparity in the 30-day incidence of stroke (9.5% vs. 1.7%).

CONCLUSIONS: Slow-flow during carotid intervention with EPDs is a frequent event that is associated with an excess risk of periprocedural stroke. The association of the phenomenon with clinically symptomatic carotid lesions and use of larger stent diameters suggests that embolization of vulnerable plaque elements may play a pathogenic role.

Abbreviations and Acronyms
  ACT = activated clotting time
  EPD = embolic protection device
  ICA = internal carotid artery
  TIA = transient ischemic attack




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1689 - 1706.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement